tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market

Conduit Pharmaceuticals (CDT) Financial Statements

28 Followers

Conduit Pharmaceuticals Financial Overview

Conduit Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.121; its P/E ratio is -24.40; Conduit Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -2.44M$ 1.99M$ -130.98K$ 256.83K$ -413.18K
EBITDA$ -2.00M-$ -130.98K$ 256.83K$ -413.18K
Net Income Common Stockholders$ -7.38M$ 1.99M$ -283.71K$ 180.27K$ 562.81K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.23M$ 8.64M$ 277.76K$ 90.61K$ 345.78K
Total Assets$ 7.22M$ 12.02M$ 23.69M$ 23.97M$ 137.52M
Total Debt$ 185.00K$ 177.00K$ 750.00K$ 300.00K$ 0.00
Net Debt$ -4.04M$ -8.47M$ 472.24K$ 209.39K$ -345.78K
Total Liabilities$ 7.68M$ 13.10M$ 6.66M$ 6.59M$ 5.05M
Stockholders Equity$ -457.00K$ -1.08M$ -6.07M$ -5.48M$ 132.47M
Cash Flow-
Free Cash Flow$ -4.80M-$ -620.74K$ -599.82K$ -382.30K
Operating Cash Flow$ -4.80M$ -1.68M$ -620.74K$ -599.82K$ -382.30K
Investing Cash Flow$ 497.00K$ -114.24M$ 594.24K$ 113.88M$ 0.00
Financing Cash Flow$ -414.00K$ 124.66M$ 213.65K$ -113.53M$ 0.00
Currency in USD

Conduit Pharmaceuticals Earnings and Revenue History

Conduit Pharmaceuticals Debt to Assets

Conduit Pharmaceuticals Cash Flow

Conduit Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis